Ultimele actualizari :
29/10/2024
Citostatic   Topotecan  
Injectabil
Stabilitatea in solutie Stabilitatea in amestec Factorii care influenteaza stabilitatea Compatibilitate Microunde Bibliografie pdf
   Formula chimica  

Denumirea comerciala   Denumirea comerciala     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acumil Mexic
Camtoop Mexic
Cantop India
Hycamtin Arabia Saudita, Australia, Austria, Belgia, Brazilia, Canada, Chilli, Columbia, Danemarca, Ecuador, Egipt, Elvetia, Emiratele Arabe Unite, Finlanda, Franta, Germania, Grecia, Irlanda, Islanda, Italia, Japonia, Luxemburg, Malaezia, Marea Britanie, Norvegia, Olanda, Polonia, Portugalia, Spania, SUA, Suedia, Turcia, Ungaria, Venezuela
Oncotecan Columbia, Ecuador
Potactasol Argentina, Belgia, Germania, Norvegia, Romania
Tekan L Turcia
Topodria Columbia
Topokebir Argentina, Peru
Toposec Peru
Topotecan Belgia, Canada, Columbia, Germania, Marea Britanie, Norvegia, Peru, Romania, Spania
Topotel Egipt
Toranex Mexic
Tpopoxin Turcia
Viatopin Ungaria
Bibliografie   Injectabil   Bibliografie : Topotecan  
tip publicare
753 Laborator Topotecan (Topotecan Hospira®) - Summary of Product Characteristics
Hospira 2016
823 ziar Patel K, Craig SB, McBride MG, Palepu NR.
Microbial inhibitory properties and stability of topotecan hydrochloride injection.
Am J Health-Syst Pharm 1998 ; 55: 1584-1587.
1026 ziar Mayron D, Gennaro AR.
Stability and compatibility of topotecan hydrochloride with selected drugs.
Am J Health-Syst Pharm 1999 ; 56: 875-881.
1075 ziar Craig SB, Bhatt UH, Patel K.
Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers.
J Pharm Biomed Anal 1997 ; 16: 199-205.
1274 ziar Krämer I, Thiesen J.
Pharmazeutische aspekte von topotecan-infusionen.
TAP Pharmazeutische Zeitung 1997 ; 31: 30-33.
1423 ziar Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1425 ziar Krämer I, Thiesen J.
Stability of topotecan infusion solutions in polyvinylchloride bags and elastomeric portable infusion devices.
J Oncol Pharm Practice 1999 ; 5: 75-82.
1662 ziar Trissel LA, Saenz CA, Ingram DS, Ogundele AB.
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
J Oncol Pharm Practice 2002 ; 8: 33-37.
1953 ziar Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1976 ziar Trissel LA, Xu QA.
Physical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated Y-site administration.
Int J Pharm Compound 2005 ; 9, 3: 238-241.

  Mentions Légales